Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To compare evaluating Clinical outcomes for patients treated with with or without breast cancer patients comorbidity for sever COVID-19 infection in breast cancer patients versus non cancer patients and evaluating Tocilizumab efficacy versus traditional therapy
Epistemonikos ID: 4ee6d8b49970777c7314b391c96ebee7f95430a6
First added on: May 05, 2021